There are multiple chapters near you. Select your preferred chapter.
In a new study published in Lupus Science & Medicine, researchers examined the performance of people with systemic lupus ...
The U.S. Food & Drug Administration has granted approval for a Phase 1 study to evaluate the safety and efficacy of ...
A new study published in Lupus Science & Medicine found a new diagnostic and disease activity monitoring biomarker for systemic lupus erythematosus (SLE) which could help understand pathogenesis, ...
The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.
The U.S. Food & Drug Administration has granted approval for a Phase 1 study to evaluate the safety and efficacy of investigational therapy, CB-010, for treatment of lupus nephritis (LN). The GALLOP ...
Understanding the immune cells that spur inflammation in lupus nephritis (LN) can help advance knowledge of disease progression and identify new treatments. A new study discovered that macrophages, a ...
Understanding the immune cells that spur inflammation in lupus nephritis (LN) can help advance knowledge of disease progression and identify new treatments. A new study discovered that macrophages, a ...
Recently, an international task force provided the first set of recommendations for physical activity that provide an ...
The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results